Cargando…

Use of Anti-Retroviral Therapy in Tuberculosis Patients on Second-Line Anti-TB Regimens: A Systematic Review

INTRODUCTION: Use of antiretroviral therapy (ART) during treatment of drug susceptible tuberculosis (TB) improves survival. However, data from HIV infected individuals with drug resistant TB are lacking. Second line TB drugs when combined with ART may increase drug interactions and lead to higher ra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arentz, Matthew, Pavlinac, Patricia, Kimerling, Michael E., Horne, David J., Falzon, Dennis, Schünemann, Holger J., Royce, Sarah, Dheda, Keertan, Walson, Judd L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3489892/ https://www.ncbi.nlm.nih.gov/pubmed/23144818 http://dx.doi.org/10.1371/journal.pone.0047370

Ejemplares similares

Association of anti-tuberculosis drug concentrations in hair and treatment outcomes in MDR- and XDR-TB
por: Metcalfe, John, et al.
Publicado: (2019)

Systematic Review of the Performance of Rapid Rifampicin Resistance Testing for Drug-Resistant Tuberculosis
por: Arentz, Matthew, et al.
Publicado: (2013)

GenoType(®) MTBDRsl assay for resistance to second‐line anti‐tuberculosis drugs
por: Theron, Grant, et al.
Publicado: (2016)

Characterizing plasma albumin concentration changes in TB/HIV patients on anti retroviral and anti –tuberculosis therapy
por: Bisaso, Kuteesa R, et al.
Publicado: (2014)

Erratum to: Characterizing plasma albumin concentration changes in TB/HIV patients on anti retroviral and anti –tuberculosis therapy
por: Bisaso, Kuteesa R, et al.
Publicado: (2015)

The diagnostic accuracy of the GenoType® Mtbdrsl assay for the detection of resistance to second-line anti-tuberculosis drugs
por: Theron, Grant, et al.
Publicado: (2014)

Is intermittent short-course anti-TB regimen as efficient and safe as daily anti-TB regimen for treating childhood TB?
por: Bhaumik, Soumyadeep
Publicado: (2015)

Pulmonary tuberculosis screening in anti-retroviral treated adults living with HIV in Kenya
por: Gersh, Jill K., et al.
Publicado: (2021)

Evaluating Latent Tuberculosis Infection Test Performance Using Latent Class Analysis in a TB and HIV Endemic Setting
por: Adams, Shahieda, et al.
Publicado: (2019)

Latent Tuberculosis Infection–associated Immunodiagnostic Test Responses as Biomarkers of Incipient Tuberculosis: Fruitful or Futile?
por: Dheda, Keertan, et al.
Publicado: (2020)

Effect of anti-retroviral therapy on oxidative stress in hospitalized HIV-infected adults with and without TB
por: Musisi, Emmanuel, et al.
Publicado: (2018)

Changes in lipidomic profile by anti-retroviral treatment regimen: An ACTG 5257 ancillary study
por: Chaudhary, Ninad S., et al.
Publicado: (2021)

Same-Day Tools, Including Xpert Ultra and IRISA-TB, for Rapid Diagnosis of Pleural Tuberculosis: a Prospective Observational Study
por: Meldau, Richard, et al.
Publicado: (2019)

Selection and Application of ssDNA Aptamers to Detect Active TB from Sputum Samples
por: Rotherham, Lia S., et al.
Publicado: (2012)

Towards all-oral and shorter treatment regimens for drug-resistant tuberculosis
por: Weyer, Karin, et al.
Publicado: (2018)

Serious Treatment Related Adverse Drug Reactions amongst Anti-Retroviral Naïve MDR-TB Patients
por: Van der Walt, Martha, et al.
Publicado: (2013)

What is new in the WHO consolidated guidelines on drug-resistant tuberculosis treatment?
por: Sharma, Surendra K., et al.
Publicado: (2019)

Adherence to anti-retroviral drugs
por: Roy, Manas Pratim
Publicado: (2016)

Determine TB-LAM lateral flow urine antigen assay for HIV-associated tuberculosis: recommendations on the design and reporting of clinical studies
por: Lawn, Stephen D, et al.
Publicado: (2013)

An Optimal Diagnostic Strategy for Tuberculosis in Hospitalized HIV-Infected Patients Using GeneXpert MTB/RIF and Alere Determine TB LAM Ag
por: Esmail, Aliasgar, et al.
Publicado: (2020)

A second-generation anti TB vaccine is long overdue
por: Castañón-Arreola, Mauricio, et al.
Publicado: (2004)

Immunological response after initiation of second line anti-retroviral therapy in HIV patients
por: Achappa, Basavaprabhu, et al.
Publicado: (2012)

Variation in missed doses and reasons for discontinuation of anti-tuberculosis drugs during hospital treatment for drug-resistant tuberculosis in South Africa
por: Pietersen, Elize, et al.
Publicado: (2023)

The use of anti-tuberculosis therapy for latent TB infection
por: Denholm, Justin T, et al.
Publicado: (2010)

Delayed initiation of anti-retroviral therapy in TB/HIV co-infected patients, Sanyati District, Zimbabwe, 2011-2012
por: Maponga, Brian Abel, et al.
Publicado: (2015)

Improved outcomes from HIV/TB co-infection in Singapore following a switch to earlier anti-retroviral therapy
por: Young, Barnaby, et al.
Publicado: (2014)

Assessment of Effective Anti-TB Regimens and Adverse Outcomes Related Risk Factors in the Elderly and Senile-Aged TB Patients
por: Guo, Jing, et al.
Publicado: (2023)

Applications of RNA structure analysis to retroviral packaging and anti-retroviral therapeutic discovery
por: Weeks, Kevin M, et al.
Publicado: (2011)

World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update
por: Falzon, Dennis, et al.
Publicado: (2017)

The diagnosis and management of dehydration in children with wasting or nutritional edema: A systematic review
por: Tsegaye, Adino Tesfahun, et al.
Publicado: (2023)

C-Tb skin test to diagnose Mycobacterium tuberculosis infection in children and HIV-infected adults: A phase 3 trial
por: Aggerbeck, Henrik, et al.
Publicado: (2018)

TIME Impact – a new user-friendly tuberculosis (TB) model to inform TB policy decisions
por: Houben, R. M. G. J., et al.
Publicado: (2016)

The Internet of Things to come: digital technologies and the End TB Strategy
por: Falzon, Dennis, et al.
Publicado: (2016)

New anti-tuberculosis drugs and regimens: 2015 update
por: D'Ambrosio, Lia, et al.
Publicado: (2015)

An autoimmune disease prevented by anti-retroviral drugs
por: Beck-Engeser, Gabriele B, et al.
Publicado: (2011)

The sense behind retroviral anti-sense transcription
por: Manghera, Mamneet, et al.
Publicado: (2017)

Can Point-of-Care Urine LAM Strip Testing for Tuberculosis Add Value to Clinical Decision Making in Hospitalised HIV-Infected Persons?
por: Peter, Jonathan G., et al.
Publicado: (2013)

Clinical presentation and outcome of Tuberculosis in Human Immunodeficiency Virus infected children on anti-retroviral therapy
por: Walters, Elisabetta, et al.
Publicado: (2008)

Treating tuberculosis with high doses of anti-TB drugs: mechanisms and outcomes
por: Xu, Yuhui, et al.
Publicado: (2017)

What is the Cost of Diagnosis and Management of Drug Resistant Tuberculosis in South Africa?
por: Pooran, Anil, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_oq7k322ffmhnosqc4alg7i37ge